Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix<sup>®</sup>30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE<sup>™</sup>observational study
International journal of clinical practice